Malignant development of proliferative verrucous/multifocal leukoplakia: A critical systematic review, meta‐analysis and proposal of diagnostic criteria

Background Proliferative verrucous/multifocal leukoplakia (PVML) is an oral potentially malignant disorder (OPMD) that exhibits high rates of malignant development (MD). This study aimed to analyse the risk of MD of PVML, as well as to investigate the possible risk factors associated with its malign...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of oral pathology & medicine 2022-01, Vol.51 (1), p.30-38
Hauptverfasser: Lafuente Ibáñez de Mendoza, Irene, Lorenzo Pouso, Alejandro I., Aguirre Urízar, José M., Barba Montero, Catalina, Blanco Carrión, Andrés, Gándara Vila, Pilar, Pérez Sayáns, Mario
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Proliferative verrucous/multifocal leukoplakia (PVML) is an oral potentially malignant disorder (OPMD) that exhibits high rates of malignant development (MD). This study aimed to analyse the risk of MD of PVML, as well as to investigate the possible risk factors associated with its malignization. Methods A bibliographical search of the PubMed, Embase, Web of Science, and Scopus databases was conducted. PVML MD rates were calculated as a pooled proportion, and the risk factors were calculated as risk ratios, using fixed and random models based on the presence of heterogeneity. Results From a total of 417 records, 16 articles were retrieved for inclusion. The subgroup analysis revealed a higher MD rate in the studies that were conducted in America, and, likewise, said studies involved a longer follow‐up time (>6 years). There was a non‐significant lower risk of malignization among males. A negative correlation was observed between MD and the year in which the studies were published. Conclusions The pooled MD of PVML was 65.8% (95% CI: 55.3–76.2, p 
ISSN:0904-2512
1600-0714
DOI:10.1111/jop.13246